Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02062671
Recruitment Status : Unknown
Verified February 2014 by Hans Dieperink, Odense University Hospital.
Recruitment status was:  Recruiting
First Posted : February 14, 2014
Last Update Posted : February 14, 2014
Information provided by (Responsible Party):
Hans Dieperink, Odense University Hospital

Brief Summary:
In patients with polycystic kidney disease, pain may be resistant to drug therapy and may reduce quality of life. This study investigate the effect of renal denervation on this pain.

Condition or disease Intervention/treatment Phase
Adult Polycystic Kidney Disease Procedure: renal denervation Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : February 2014
Estimated Primary Completion Date : February 2015
Estimated Study Completion Date : February 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Diseases

Arm Intervention/treatment
Experimental: immediate renal denervation
immediate renal denervation
Procedure: renal denervation
Active Comparator: delayed renal denervation
delayed renal denervation
Procedure: renal denervation

Primary Outcome Measures :
  1. Pain [ Time Frame: 6 months ]
    Pain from VAS

Secondary Outcome Measures :
  1. Quality of Life (QoL) [ Time Frame: 6 months ]

Other Outcome Measures:
  1. kidney function [ Time Frame: 6 months ]
    creatinine clearance

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Pain limiting daily activities in spite of pain killers, ADPKD

Exclusion Criteria:

  • Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02062671

Contact: Hans Dieperink, MD +4520598851
Contact: Marie Blicher, MD + 45 65415305

Department of Nephrology Recruiting
Odense, Denmark, 5000
Contact: Hans Dieperink, MD    004520598851   
Principal Investigator: Hans Dieperink, MD         
Sponsors and Collaborators
Odense University Hospital

Responsible Party: Hans Dieperink, Head of Department, MD, Odense University Hospital Identifier: NCT02062671     History of Changes
Other Study ID Numbers: RePKID
S-20130085 ( Registry Identifier: De Videnskabsetiske komitéer for Region Syddanmark )
First Posted: February 14, 2014    Key Record Dates
Last Update Posted: February 14, 2014
Last Verified: February 2014

Keywords provided by Hans Dieperink, Odense University Hospital:
renal denervation

Additional relevant MeSH terms:
Kidney Diseases
Polycystic Kidney Diseases
Polycystic Kidney, Autosomal Dominant
Urologic Diseases
Kidney Diseases, Cystic
Abnormalities, Multiple
Congenital Abnormalities
Genetic Diseases, Inborn